What does CUSIP 29089Q105 represent in this 13F holders report?

CUSIP 29089Q105 is the security identifier for EBS - Emergent BioSolutions Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held EBS - Emergent BioSolutions Inc. - Common Stock in Q2 2014?

157 institutional investors reported EBS - Emergent BioSolutions Inc. - Common Stock for Q2 2014. Use the holders table for investor-level position and value details.

Emergent BioSolutions Inc. - Common Stock (EBS)

CUSIP: 29089Q105

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Equity / Common Stock
Shares outstanding: 52,021,849
Total 13F shares: 28,744,311
Share change: +165,336
Total reported value: $645,587,994
Price per share: $22.46
Number of holders: 157
Value change: -$436,657
Number of buys: 90
Number of sells: 75

Quarterly Holders Quick Answers

What is CUSIP 29089Q105?
CUSIP 29089Q105 identifies EBS - Emergent BioSolutions Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2014
Previous quarter: Q1 2014

Recent filing periods for CUSIP 29089Q105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EBS - Emergent BioSolutions Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bank of New York Mellon Corp	13F	Company	6.5%	3,362,908	$84,982,000	—	31 Mar 2014	13F
VANGUARD GROUP INC	13F	Company	3.8%	1,978,531	$49,997,000	—	31 Mar 2014	13F
Broadfin Capital, LLC	13F	Company	3.5%	1,805,352	$45,621,000	—	31 Mar 2014	13F
BlackRock Fund Advisors	13F	Company	3%	1,535,713	$38,807,000	—	31 Mar 2014	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2.5%	1,278,440	$32,306,000	—	31 Mar 2014	13F
STATE STREET CORP	13F	Company	2.4%	1,255,568	$31,729,000	—	31 Mar 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.9%	981,671	$24,807,000	—	31 Mar 2014	13F
LOOMIS SAYLES & CO L P	13F	Company	1.6%	856,468	$21,643,000	—	31 Mar 2014	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.5%	762,898	$19,278,000	—	31 Mar 2014	13F
Invesco Ltd.	13F	Company	1.2%	619,401	$15,652,000	—	31 Mar 2014	13F
Numeric Investors LLC	13F	Company	1.2%	618,859	$15,639,000	—	31 Mar 2014	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	1.2%	608,494	$15,377,000	—	31 Mar 2014	13F
FMR LLC	13F	Company	1.2%	600,362	$15,171,000	—	31 Mar 2014	13F
D. E. Shaw & Co., Inc.	13F	Company	0.89%	462,548	$11,689,000	—	31 Mar 2014	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.88%	455,336	$11,506,000	—	31 Mar 2014	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.78%	406,509	$10,273,000	—	31 Mar 2014	13F
SAC Capital Advisors LP	13F	Company	0.77%	401,847	$10,155,000	—	31 Mar 2014	13F
Fisher Asset Management, LLC	13F	Company	0.77%	398,670	$10,074,000	—	31 Mar 2014	13F
NORTHERN TRUST CORP	13F	Company	0.76%	394,774	$9,975,000	—	31 Mar 2014	13F
GLENMEDE TRUST CO NA	13F	Company	0.65%	336,278	$8,497,000	—	31 Mar 2014	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.62%	323,000	$8,163,000	—	31 Mar 2014	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.61%	314,749	$7,954,000	—	31 Mar 2014	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.57%	295,834	$7,476,000	—	31 Mar 2014	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.53%	276,964	$6,999,000	—	31 Mar 2014	13F
Gotham Asset Management, LLC	13F	Company	0.5%	258,760	$6,539,000	—	31 Mar 2014	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.46%	241,418	$6,101,000	—	31 Mar 2014	13F
RUSSELL FRANK CO/	13F	Company	0.46%	238,698	$6,032,000	—	31 Mar 2014	13F
MORGAN STANLEY	13F	Company	0.43%	223,305	$5,643,000	—	31 Mar 2014	13F
Pine River Capital Management L.P.	13F	Company	0.42%	216,100	$5,461,000	—	31 Mar 2014	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.39%	202,288	$5,111,000	—	31 Mar 2014	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.38%	198,490	$5,016,000	—	31 Mar 2014	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.37%	193,383	$4,886,000	—	31 Mar 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.37%	192,053	$4,852,000	—	31 Mar 2014	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.36%	187,000	$4,725,000	—	31 Mar 2014	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.36%	185,231	$4,681,000	—	31 Mar 2014	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.36%	184,753	$4,669,000	—	31 Mar 2014	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.35%	183,400	$4,634,000	—	31 Mar 2014	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.35%	182,243	$4,605,000	—	31 Mar 2014	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.35%	180,225	$4,554,000	—	31 Mar 2014	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.34%	178,584	$4,513,000	—	31 Mar 2014	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.32%	167,371	$4,229,000	—	31 Mar 2014	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.32%	166,434	$4,205,000	—	31 Mar 2014	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.26%	133,490	$3,373,000	—	31 Mar 2014	13F
Curi Capital, LLC	13F	Company	0.26%	133,253	$3,367,000	—	31 Mar 2014	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.25%	131,662	$3,328,000	—	31 Mar 2014	13F
Spark Investment Management LLC	13F	Company	0.25%	128,500	$3,247,000	—	31 Mar 2014	13F
ClariVest Asset Management LLC	13F	Company	0.23%	117,515	$2,971,000	—	31 Mar 2014	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.23%	117,371	$2,966,000	—	31 Mar 2014	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.22%	115,601	$2,921,000	—	31 Mar 2014	13F
Allianz Asset Management GmbH	13F	Company	0.22%	112,536	$2,844,000	—	31 Mar 2014	13F

Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2014

As of 30 Jun 2014, Emergent BioSolutions Inc. - Common Stock (EBS) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,744,311 shares. The largest 10 holders included Bank of New York Mellon Corp, Broadfin Capital, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, State Street Corp, BlackRock Institutional Trust Company, N.A., LOOMIS SAYLES & CO L P, NUMERIC INVESTORS LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 157 institutional shareholders reporting positions in this security for the Q2 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2014 vs Q1 2014 Across Filers

Q1 2014 holders

163

Q2 2014 holders

157

Holder diff

-6

Investor	Q1 2014 Shares	Q2 2014 Shares	Share Diff	Share Chg %	Q1 2014 Value $	Q2 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.